eMeasure Title

Functional Status Assessments for Congestive Heart Failure

eMeasure Identifier (Measure Authoring Tool) 90 eMeasure Version number 6.2.000
NQF Number Not Applicable GUID bb9b8ef7-0354-40e0-bec7-d6891b7df519
Measurement Period January 1, 20XX through December 31, 20XX
Measure Steward Centers for Medicare & Medicaid Services (CMS)
Measure Developer National Committee for Quality Assurance
Endorsed By None
Percentage of patients 65 years of age and older with congestive  heart failure who completed initial and follow-up patient-reported functional status assessments
Limited proprietary coding is contained in the Measure specifications for user convenience. Users of proprietary code sets should obtain all necessary licenses from the owners of the code sets.  NCQA disclaims all liability for use or accuracy of any CPT or other codes contained in the specifications.

CPT(R) contained in the Measure specifications is copyright 2004-2015 American Medical Association. LOINC(R) copyright 2004-2015 Regenstrief Institute, Inc. This material contains SNOMED Clinical Terms(R) (SNOMED CT[R]) copyright 2004-2015 International Health Terminology Standards Development Organisation. ICD-10 copyright 2015 World Health Organization. All Rights Reserved.
These performance Measures are not clinical guidelines and do not establish a standard of medical care, and have not been tested for all potential applications.


Due to technical limitations, registered trademarks are indicated by (R) or [R] and unregistered trademarks are indicated by (TM) or [TM].
Measure Scoring Proportion
Measure Type Process
Risk Adjustment
Rate Aggregation
Patients living with CHF often have poor functional status and health-related quality of life, which declines as the disease progresses (Allen et al. 2012). In addition, their care is often complicated by multiple comorbidities. To assist in managing these complex patients, the American College of Cardiology Foundation and American Heart Association recommend collecting initial and repeat assessments of a patients' function and ability to complete desired activities of daily living (Hunt et al. 2009). The American Heart Association has also released scientific statements emphasizing the collection of patient-reported health status (for example, functional limitations, symptom burden, quality of life) from CHF patients as an important means of establishing a dynamic conversation between patient and provider regarding care goals and the patient's priorities (Allen et al. 2012; Rumsfeld et al. 2013).
Clinical Recommendation Statement
American College of Cardiology Foundation/American Heart Association (2013): Every patient with HF should have a clear, detailed, and evidence-based plan of care that ensures the achievement of GDMT (guideline-directed medical therapy) goals, effective management of comorbid conditions, timely follow-up with the health care team, appropriate dietary and physical activities, and compliance with secondary prevention guidelines for cardiovascular disease. This plan of care should be updated regularly and made readily available to all members of each patient's health care team.
(Class of recommendation: I; Level of evidence: C) 
Level C: Only consensus opinion of experts, case studies, or standard of care 
Class I: Procedure/treatment should be performed/administered
Improvement Notation
A higher score indicates better quality
Allen, L.A., L.W. Stevenson, K.L. Grady, et al. "Decision Making in Advanced Heart Failure: A Scientific Statement from the American Heart Association." Circulation, vol. 125, 2012, pp. 1928-1952. doi: 10.1161/CIR.0b013e31824f2173.
Hunt, S.A., W.T. Abraham, et al. "2009 Focused Update Incorporated into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults." Circulation, vol. 119, 2009, pp. e391-e479. doi: 10.1161/CIRCULATIONAHA.109.192065.
Rumsfeld, J.S., K.P. Alexander, D.C. Goff, et al. "Cardiovascular Health: The Importance of Measuring Patient-Reported Health Status: A Scientific Statement from the American Heart Association." Circulation, vol. 127, no. 22, 2013, pp. 2233-2249. doi: 10.1161/CIR.0b013e3182949a2e.
American College of Cardiology Foundation/American Heart Association. "Guideline for the Management of Heart Failure: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines." Circulation, vol. 128, 2013, pp. e240-e327. doi: 10.1161/CIR.0b013e31829e8776.
Initial encounter: The first encounter during the first 185 days of the measurement year. 

Follow-up encounter: The last encounter that is at least 30 days but no more than 180 days after the initial encounter.

A Functional Status Assessment (FSA) is based on administration of a validated instrument to eligible patients that asks patients to answer questions related to various domains including: pain, physical function, emotional well-being, health-related quality of life, symptom acuity.

The same FSA instrument must be used for the initial and follow-up assessment.
Transmission Format
Initial Population
Patients 65 years of age and older who had two outpatient encounters during the measurement year and a diagnosis of congestive heart failure
Equals Initial Population
Denominator Exclusions
Patients with severe cognitive impairment or patients with a diagnosis of cancer
Patients with patient reported functional status assessment results (eg, VR-12; VR-36; MLHF-Q; KCCQ; PROMIS-10 Global Health, PROMIS-29) present in the EHR within two weeks before or during the initial encounter and the follow-up encounter during the measurement year
Numerator Exclusions
Not Applicable
Denominator Exceptions
Supplemental Data Elements
For every patient evaluated by this measure also identify payer, race, ethnicity and sex

Table of Contents

Population Criteria

Data Criteria (QDM Variables)

Data Criteria (QDM Data Elements)

Supplemental Data Elements

Risk Adjustment Variables

Measure Set